Macrophage-Mediated Delivery of Hypoxia-Activated Prodrug Nanoparticles

被引：2
|
作者：
Evans, Michael A.
Shields, C. Wyatt
Krishnan, Vinu
Wang, Lily Li-Wen
Zhao, Zongmin
Ukidve, Anvay
Lewandowski, Michael
Gao, Yongsheng
Mitragotri, Samir
机构：
来源：
ADVANCED THERAPEUTICS | 2020年 / 3卷 / 11期
关键词：
D O I：
10.1002/adtp.202000183
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] The role of bystander effects in the an hypoxia-activated prodrug PR-104
    Foehrenbacher, Annika
    Patel, Kashyap
    Abbattista, Maria R.
    Guise, Chris P.
    Secomb, Timothy W.
    Wilson, William R.
    Hicks, Kevin O.
    FRONTIERS IN ONCOLOGY, 2013, 3
  • [22] DTP-006: a novel, orally bioavailable hypoxia-activated prodrug
    Niemans, R.
    Yaromina, A.
    Theys, J.
    Ashoorzadeh, A.
    Anderson, R.
    Bull, M.
    Guise, C.
    Hsu, H. L.
    Abbattista, M.
    Mowday, A.
    Patterson, A. V.
    Smaill, J. B.
    Ackerley, D. F.
    Dubois, L.
    Lambin, P.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S107 - S107
  • [23] Influence of the hypoxia-activated prodrug Evofosfamide on glycolytic metabolism of canine glioma
    Yamazaki, Hiroki
    Onoyama, Seio
    Gotani, Shunichi
    Deguchi, Tatsuya
    Tamura, Masahiro
    Ohta, Hiroshi
    Iwano, Hidetomo
    Nishida, Hidetaka
    Akiyoshi, Hideo
    CANCER SCIENCE, 2024, 115 : 559 - 559
  • [24] Developments of hypoxia-activated molecularly targeted prodrug and applications for chemoradiation therapy
    Ikeda, Yutaka
    Nagasaki, Yukio
    CANCER SCIENCE, 2024, 115 : 718 - 718
  • [25] Discovery of TH-302: An achiral hypoxia-activated cytotoxic prodrug
    Hart, C. P.
    Ammons, S.
    Duan, J. X.
    Jung, D.
    Wang, J.
    Jiao, H.
    Meng, F.
    Lan, L.
    Evans, J. W.
    Matteucci, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [26] Hypoxia-Activated and Indomethacin-Mediated Theranostic Prodrug Releasing Drug On-Demand for Tumor Imaging and Therapy
    Peng, Xiaoran
    Gao, Jiaxin
    Yuan, Yumeng
    Liu, Haitong
    Lei, Weiyan
    Li, Shenghui
    Zhang, Jinchao
    Wang, Shuxiang
    BIOCONJUGATE CHEMISTRY, 2019, 30 (11) : 2828 - 2843
  • [27] Hypoxia-Activated Anticancer Prodrug for Bioimaging, Tracking Drug Release, and Anticancer Application
    Liu, Wei
    Liu, Haitong
    Peng, Xiaoran
    Zhou, Guoqiang
    Liu, Dandan
    Li, Shenghui
    Zhang, Jinchao
    Wang, Shuxiang
    BIOCONJUGATE CHEMISTRY, 2018, 29 (10) : 3332 - 3343
  • [28] Hypoxia-dependent in vivo activity of the hypoxia-activated prodrug (HAP) TH-302
    Sun, Jessica D.
    Liu, Qian
    Ahluwalia, Dharmendra
    Wang, Yan
    Meng, Fanying
    Bhupathi, Deepthi
    Curd, John G.
    Matteucci, Mark D.
    Hart, Charles P.
    CANCER RESEARCH, 2011, 71
  • [29] Investigation of mesalazine-cobalt(III) complexes for hypoxia-activated prodrug development
    Santana, Savyo S.
    Lanznaster, Mauricio
    INORGANIC CHEMISTRY COMMUNICATIONS, 2023, 153
  • [30] A Semiconducting Polymer Nano-prodrug for Hypoxia-Activated Photodynamic Cancer Therapy
    Cui, Dong
    Huang, Jiaguo
    Zhen, Xu
    Li, Jingchao
    Jiang, Yuyan
    Pu, Kanyi
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2019, 58 (18) : 5920 - 5924
12345